This allows the body time to adapt and tolerate the medication while minimizing side effects
Generally no they engage different mechanisms
In fact, the diabetes risk associated with a high energy intake was greater than that of consuming unhealthy fats
Some may feel mild side effects like nausea or stomach upset
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): A phase 3, double-blind, randomised, multicentre, placebo-controlled trial
Prolotherapy has been shown to reduce pain and stiffness, and improve knee function and quality of life in knee OA patients